Matsuda Masaru 4
4 · Arcutis Biotherapeutics, Inc. · Filed Aug 5, 2025
Insider Transaction Report
Form 4
Matsuda Masaru
See Remarks
Transactions
- Sale
Common Stock
2025-08-04$14.33/sh−6,330$90,687→ 197,364 total
Footnotes (3)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.965 to $14.675, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,095 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2025.